Back to Trades
Sell4
Kiniksa Pharmaceuticals International, plc
KNSA
Total Value
$542.8K
Net $345.1K sold
Sales
$345.1K
1 transaction
Company Information
- Company Name
- Kiniksa Pharmaceuticals International, plc
- Ticker Symbol
- KNSA
- CIK
- 0001730430
Insider Information
- Name
- Quart Barry D
- Role
- Insider
Filing Details
- Filing Date
- Apr 8, 2026
- Transaction Date
- Apr 6, 2026
- Accession Number
- 0001384243-26-000008
- Form Type
- 4
- Net Trading Amount
- -$345.1K
Non-Derivative Transactions
| Date | Security | Shares | Price | Type | Value |
|---|---|---|---|---|---|
| Apr 6, 2026 | Class A Ordinary Share | 6,901 | $14.33 | Exercise | $98.9K |
| Apr 6, 2026 | Class A Ordinary Share | 6,901 | $50.00 | Sale | $345.1K |
Derivative Transactions
| Date | Security | Shares | Exercise Price | Type | Value |
|---|---|---|---|---|---|
| Apr 6, 2026 | Derivative | 6,901 | $14.33 | Exercise | $98.9K |
Footnotes
- (F1)This transaction was effected pursuant to a 10b5-1 plan executed by the reporting person on September 11, 2025.
- (F2)This transaction was executed in multiple trades through a broker-dealer at prices ranging between $50.00 and $50.015. The price reported in this column reflects a weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price.
- (F3)The option is fully vested and exercisable.